Molecular characterization of Vig4/Vrg4 GDP-mannose transporter of the yeast Saccharomyces cerevisiae  by Abe, Masato et al.
Molecular characterization of Vig4/Vrg4 GDP-mannose transporter of
the yeast Saccharomyces cerevisiae
Masato Abe, Hitoshi Hashimoto, Koji Yoda*
Department of Biotechnology, The University of Tokyo, Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
Received 5 August 1999; received in revised form 25 August 1999
Abstract Saccharomyces cerevisiae Vig4/Vrg4 protein is a
Golgi membrane protein which has multiple transmembrane
domains and is essential for transport of GDP-mannose across
the Golgi membrane. By immunoprecipitation of detergent-
solubilized tagged protein, we found that this protein exists as
oligomer. Two mutants vig4-1 and vig4-2 had amino acid
substitutions in the C-terminal region, Ala286Val and
Ser278Cys, respectively. In accord with these mutations,
trimming of the C-terminal hydrophobic part close to the region
impaired the function and traffic of the proteins from the
endoplasmic reticulum to the Golgi compartments.
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1. Introduction
In eukaryotes, many polypeptides are modi¢ed with glyco-
syl residues which contribute to their stability and function.
N-glycosylation on suitable asparagine and O-glycosylation
on serine or threonine occurs during the translocation of the
polypeptides in the endoplasmic reticulum (ER) and tra⁄c in
the Golgi compartments. In Saccharomyces cerevisiae, man-
nose is the sole sugar added on protein except two N-acetyl-
glucosamine (GlcNAc) residues which link each N-glycan to
asparagine. The linkage between the polypeptide and sugar is
made in the ER using dolichol intermediates and then elon-
gation of mannose moiety occurs in the Golgi using GDP-
mannose [1^3]. GDP-mannose is synthesized in the cytosol by
Vig9 GDP-mannose pyrophosphorylase [4]. It should be
transported across the Golgi membrane into the lumen by a
speci¢c nucleotide sugar transporter which also functions as
an antiporter of GMP back into the cytoplasm [5].
Among 217 recessive vig vanadate resistance and immature
glycosylation mutants of S. cerevisiae which we isolated and
classi¢ed in 9 complementation groups [4], 16 belonged to
vig4. Genetic and sequence analysis revealed that it was allelic
to the mutation named vrg4 [6,7] or van2 [8] which were sim-
ilarly enriched by vanadate-resistance [6]. Both N- and O-gly-
cosylation in the Golgi was severely a¡ected in these mutants
and the null mutant was lethal. Dean and colleagues have
reported that VRG4 encodes an essential Golgi membrane
protein containing multiple membrane-spanning domains [7]
and is required for GDP-mannose transport into the lumen of
the Golgi by in vitro analyses [9].
Addition of mannose by various mannosyltransferases is an
elaborative function of the Golgi and the supply of donor
nucleotide sugar, GDP-mannose, is the prerequisite. So,
GDP-mannose/GMP transporter should be the essential com-
ponent for the function of this organelle. As the vrg4-2 mu-
tant cell had a disordered endomembrane system [7] and
VIG4-overexpressing cell developed multiple lamellar struc-
ture similar to the Golgi apparatus of mammalian secretory
cells (our unpublished result), Vrg4/Vig4 protein might con-
cern in the architecture of the organelle. In this paper, we
report that Vig4/Vrg4 protein is oligomeric and its C-terminal
region is important for the function and conformation of this
molecule.
2. Materials and methods
2.1. Strains and media
Escherichia coli DH5K (F3 P80lacZvM15, supE44 vlacU169
hsdR17 recA1 endA1 gyrA96 thi-1 relA1) was used in plasmid con-
struction. S. cerevisiae KA31-1A (MATa vura3 vtrp1 vhis3 vleu2)
[10], K2 (MATa vig4-1 leu1) and C4 (MATK vig4-2 lys1) were used.
2.2. Plasmid construction
The DNA fragments encoding the full-length Vig4, C-terminal trun-
cated Vig4v12, Vig4v35 and Vig4v62 were prepared by polymerase
chain reaction using sense primer (nucleotide from 3968 to 3943; A
of initiation ATG was de¢ned as nucleotide 1) and antisense primers
(nucleotide 996^1031, 957^976, 884^902 and 823^841, respectively).
Primers were designed to place BamHI site at the 5P-end and XhoI
site at the 3P-end for cloning in pCH1 (2 Wm, URA3) to construct
C-terminal fusion with MYC hexamer (Vig4-MYC) [10] or pYN116
(2 Wm, URA3) to construct C-terminal fusion with HA trimer (Vig4-
HA). The expression units were cut out and subcloned in pRS314
(CEN6, TRP1) or pRS316 (CEN6, URA3) [11], if necessary.
2.3. Immunological methods
Immunoprecipitation of tagged protein, immunoblotting and indi-
rect immuno£uorescence microscopy were done as previously de-
scribed [10]. Disintegration of the cell was done by shaking with glass
beads instead of zymolyase digestion. Unbroken cells were removed
by centrifugation at 2000Ug for 5 min, before addition of detergent,
0.5% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate
(CHAPS, Sigma). In some experiments, the supernatant after centri-
fugation at 10 000Ug for 20 min (S10) was used to exclude large
membranous materials.
3. Results and discussion
3.1. Oligomerization of Vig4 protein
Some membrane transporters are reported to form homo-
dimer and leucine-zipper motifs were suggested to be involved
in oligomerization [5]. Though a leucine-zipper motif was not
found in Vrg4/Vig4 protein, we examined whether the func-
tional form of Vig4 is monomeric or oligomeric. The genes
encoding epitope-tagged derivatives, Vig4-MYC and Vig4-
HA, were constructed. The vig4 mutants show increased
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drug sensitivity and decreased protein glycosylation (Poster
and Dean [7] and our unpublished results) as a result of de-
fective transport of GDP-mannose in the Golgi complex [9].
The MYC hexamer or HA trimer tags at the C-terminus did
not impair the function of Vig4 because the defect of the vig4-
1 mutant was rescued by introduction of each plasmid (Fig.
3).
Transformant cells were broken with glass beads, unbroken
cells and debris were removed by low-speed centrifugation
(2000Ug, 5 min) and the membrane proteins were solubilized
with 0.5% CHAPS. After high-speed centrifugation
(100 000Ug, 1 h) to remove insoluble materials, the MYC-
tagged protein was collected by immunoprecipitation, and
subjected to SDS-PAGE and immunoblotting. Fig. 1A shows
that Vig4-HA protein was precipitated by anti-MYC antibody
if both proteins were expressed in the same cells (lane 3), while
it was not precipitated if only Vig4-MYC (lane 1) or Vig4-HA
(lane 2) was present in the cell. Thus, Vig4-MYC and Vig4-
HA has physical interaction. The association should be intrin-
sic and occur in vivo, because coprecipitation was not ob-
served when the detergent extracts were mixed in vitro (lane
4). Experiments using HA for immunoprecipitation and MYC
for immunoblotting gave similar results (data not shown).
The speci¢city was further supported by the fact that Vig4-
HA was not coprecipitated with other Golgi type II mem-
brane proteins, Mnn9-MYC or Sed5-MYC, in similar condi-
tions (data not shown). Recovery of Vig4-HA in the precip-
itate increased if the amount of Vig4-MYC increased (Fig.
1B). It was much reduced if Triton X-100 was used instead
of CHAPS (data not shown). Triton X-100 may interfere the
protein-protein interaction more extensively. This may suggest
some kinds of hydrophobic interaction play a role in oligomer
formation.
Fig. 1. Co-immunoprecipitation of epitope-tagged Vig4 protein after
solubilization by the detergent CHAPS. Cells were broken by glass
beads and membrane proteins were solubilized by 0.5% CHAPS.
After centrifugation at 100 000Ug for 1 h, the supernatant was ap-
plied to immunoprecipitation by anti-MYC monoclonal IgG 9E10.
Immunoprecipitates were analyzed by immunoblotting by anti-HA
monoclonal IgG 12A5 and horseradish peroxidase-conjugated goat
anti-mouse IgG and ECL detection system (Amersham). A: Deter-
gent extracts were prepared from cells expressing Vig4-MYC (lane
1), Vig4-HA (lane 2), or both (lane 3). Detergent extracts containing
Vig4-MYC and Vig4-HA were prepared separately and mixed on
ice and kept for 30 min before immunoprecipitation (lane 4).
B: Vig4-HA was produced from CEN plasmid in combination with
2 Wm vector (lane 1), 2 Wm plasmid expressing Vig4-MYC (lane 2),
or CEN plasmid expressing Vig4-MYC (lane 3).
Fig. 2. The point and deletion mutants and hydropathy pro¢les of
Vig4 protein. Hydropathy was plotted according to Kyte and Doo-
little [12] at a window of 15 amino acids. The positions of the ami-
no acid substitutions, deletions and MYC-tagging were shown sche-
matically.
Fig. 3. Activities of the deletion derivatives as assayed by rescue of
the vig4-1 mutant phenotypes. A: Congo red sensitivity was assayed
by growth of serially diluted fresh cultures spotted on the agar
plates with 0 or 50 Wg/ml of Congo red; (1) KA31-1A, (2) vig4-1/
pCH1, (3) vig4-1/pCH1-Vig4v12, (4) vig4-1/pCH1-Vig4v35, (5) vig4-
1/pCH1-Vig4v62 and (6) vig4-1/pCH1-Vig4. B: Activity staining of
invertase in 7.5% SDS-PAGE of the periplasmic fractions of the
wild-type KA31-1A and vig4-1 transformants.
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3.2. Sequence alterations in vig4 mutants
To ¢nd functionally important amino acids in Vig4, we
determined the nucleotide sequences of our mutant alleles.
In vig4-1, the 856th cytosine was replaced with thymine and
accordingly the 286th amino acid alanine was replaced with
valine. In vig4-2, the 833rd cytosine was replaced with guanine
and accordingly the 278th serine was replaced with cysteine.
These altered amino acids were only 10 amino acid apart in a
relatively less hydrophobic region between the C-terminal hy-
drophobic peaks [12] (Fig. 2).
3.3. E¡ect of truncation from the C-terminus.
As the point mutations were near the C-terminus, we con-
structed three short deletions of 12, 35 and 62 amino acids
(Fig. 2) to see the role of the C-terminal region. As shown in
Fig. 3, even the shortest deletion which removed only the
hydrophilic stretch of 12 amino acids (Vig4v12) lost the ac-
tivity to rescue the defects of vig4-1 mutation; sensitivity to
Congo red and decreased glycosylation of invertase. Other
deletions were also not functional in these respects (Fig. 3).
Glutathione S-transferase or green £uorescent protein could
be fused to the C-terminus of Vig4 without large loss of ac-
tivity (data not shown). The C-terminal 12 amino acids of
Vig4 are hydrophilic, containing 4 glutamines, 4 lysines and
1 arginine. The positive charge of this peptide may play a role
for its activity.
3.4. Oligomer formation of the mutant Vig4 derivatives
As we have shown that the wild-type Vig4 protein forms
oligomers, we next examined whether the point and deletion
mutant proteins could join in the oligomer or not. We con-
structed transformants in which the mutant Vig4 polypeptides
were tagged with MYC epitope and the wild-type Vig4 was
tagged with HA epitope. The MYC-tagged mutant protein
was collected from CHAPS-solubilized lysate by anti-MYC
Fig. 4. Coprecipitation of the wild-type Vig4-HA with MYC-tagged
mutant derivatives. A: In KA31-1A, Vig4-HA was produced from
CEN plasmid in combination with 2 Wm vector (lane 1), CEN plas-
mid expressing Vig4-MYC (lane 2), 2 Wm plasmid expressing Vig4-
1-MYC (lane 3) or 2 Wm plasmid expressing Vig4-2-MYC (lane 4).
Immunoprecipitation was done with anti-MYC antibody, and im-
munoblotting was done with anti-HA (upper) or anti-MYC (lower)
antibodies. The detergent extract was prepared from supernatant of
2000Ug, 5 min centrifugation (Total lysate). B: Similar immunopre-
cipitation was done as in (A). The precipitation probe was none
(lane 1), Vig4-MYC (lane 2), Vig4v12-MYC (lane 3), Vig4v35-
MYC (lane 4) or Vig4v62-MYC (lane 5). C: Same as (B) except
the detergent extract was prepared from the supernatant of
10 000Ug, 20 min centrifugation (S10).
Fig. 5. Intracellular localization of Vig4 and the mutant proteins
visualized by immuno£uorescent staining. Transformant cells which
produce various MYC-tagged derivatives of Vig4 were stained with
anti-MYC 9E10 and £uorescein isothiocyanate (FITC)-labelled goat
anti-mouse IgG and photographed with a BH2-RFC microscope
(Olympus, Tokyo).
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antibody and then existence of the wild-type Vig4-HA in the
precipitate was examined by immunoblotting. As shown in
Fig. 4A, Both of the two MYC-tagged point mutant proteins
joined in the oligomeric form with the wild-type Vig4-HA
protein. Three truncated proteins also coprecipitated the
HA-tagged wild-type protein (Fig. 4B). These results suggest
the C-terminal 12 amino acids are not essential for oligomer
formation. When we used the supernatant of 10 000Ug cen-
trifugation (S10) instead of total lysate, Vig4v35-MYC and
Vig47v62-MYC were not able to coprecipitate the wild-type
protein (Fig. 4C). This suggests these deletion derivatives were
on rapidly sedimenting membranes which were removed in
S10.
3.5. Localization of the mutant proteins
Intracellular localization of the MYC-tagged mutant Vig4
derivatives were examined by immuno£uorescent staining. As
shown in Fig. 5, Vig4-1, Vig4-2 and Vig4v12 protein gave
punctate staining patterns indistinguishable from the wild-
type protein. This suggests all these proteins were mainly lo-
calized in the Golgi compartment. On the other hand,
Vig4v35 and Vig4v62 gave a typical image comprised of cen-
tral ring and threads along the contour of the cell which in-
dicated that the proteins were in the ER. The localization
coincided with the rapid sedimentation of the proteins. This
suggests the C-terminal hydrophobic stretch plays a role in the
tra⁄c of Vig4 protein from the ER to the Golgi.
Although the topology should be determined precisely, we
might expect the region Ser278^Ala286 is a candidate of the
site of interaction with the transport substrates GDP-mannose
and GMP [5,9]. Crosslinking with the photoreactive analogs
of GDP-mannose should be useful to examine this issue. Site-
directed mutagenesis of these regions might also help to de-
termine the essential residues for transport of substrates.
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